Purpose This study aimed to evaluate the role of 18F-fluorodeoxyglucose (18F-FDG)
positron emission tomography (PET)/computed tomography (CT) in expression of tumor …

Objectives In the present study, we aimed to investigate the relationship between metabolic
parameters of 18 F-fluorodeoxyglucose positron emission computed tomography (18 F-FDG …

Background Programmed death-ligand 1 (PD-L1) expression is a predictive biomarker for
immunotherapy in non-small cell lung cancer (NSCLC). PD-L1 and glucose transporter 1 …

Objective: This study sought to investigate the association between 18F-fludeoxyglucose
(18F-FDG) uptake in positron emission tomography/CT (PET/CT) scans and different …

Background We conducted a meta-analysis to systematically evaluate the relationship
between programmed death-ligand 1 (PD-L1) expression and survival in patients with lung …

Background This study aimed to determine the relationship of programmed death-ligand 1
(PD-L1) expression and standardized uptake values in fluorodeoxyglucose–positron …

Programmed cell death-ligand 1 (PD-L1) expression is commonly observed in non-small
cell lung cancer (NSCLC). The prognostic value of PD-L1 expression and the maximum …

Objective The prognostic role of programmed death ligand-2 (PD-L2) expression in lung
cancer has been widely studied, however, the results are controversial. Accordingly, we …

Background Immunotherapy targeting programmed cell death 1 (PD-1) or its ligand 1 (PD-
L1) has shown promising results in non-small cell lung cancer (NSCLC) patients. Exploring …

Aim: We evaluated the metabolic characteristics of small-sized lung cancer using 18F-
fluorodeoxyglucose positron-emission tomography/computed tomography (18F-FDG …